Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue

Download Mobile App




In Other News

Image: CareDx entered an agreement to acquire Naveris for $160 million upfront, with up to $100 million in additional milestone payments.

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition

CareDx Inc. (Brisbane, CA, USA), a precision medicine company advancing clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, has entered a definitive agreement to acquire Naveris (Waltham, MA, USA). Read more
29 Apr 2026 | Industry
Image: Thermo Fisher expects the transaction with Astorg to close in the second half of 2026

Thermo Fisher Scientific to Sell Microbiology Business to Astorg

Thermo Fisher Scientific has signed a definitive agreement to sell its microbiology business to Astorg for approximately $1. Read more
29 Apr 2026 | Industry
Image: Researchers identified a set of scalable, blood-based biomarkers associated with PTSD using common clinical laboratory tests (photo courtesy of Adobe Stock)

Routine Blood Tests Identify Biomarkers Linked to PTSD

Post-traumatic stress disorder (PTSD) is associated with a range of chronic physical health conditions and affects multiple organ systems. Read more
28 Apr 2026 | Clinical Chem.
Image: Graphical abstract (Jessica L. Corredor et al., The American Journal of Human Genetics (2026). DOI: 10.1016/j.ajhg.2026.03.014)

Risk Prediction Tool Enhances Genetic Testing for Li-Fraumeni Syndrome

Li-Fraumeni syndrome is a rare hereditary cancer predisposition most often driven by germline mutations in the TP53 tumor suppressor gene. Read more
28 Apr 2026 | Molecular Diagnostics
Image: The MechanoAge platform, shown here on a microscope stage, could be used to detect breast cancer risk. (Photo courtesy of Adam Lau/Berkeley Engineering)

Microfluidic Single-Cell Assay Predicts Breast Cancer Risk

Risk stratification for breast cancer remains imprecise, as population-based models and breast density can over- or underestimate individual risk, potentially leading to over- or under-screening. Read more
27 Apr 2026 | Technology
Image: New research shows genomic data can identify which precancerous cells progress to myeloid leukemia in children with Down syndrome (photo courtesy of Shutterstock)

Genetic Signature Predicts Myeloid Leukemia Risk in Down Syndrome

Children with Down syndrome face a markedly increased risk of myeloid leukemia, yet early lesions and pre-cancerous cells can appear indistinguishable under the microscope. Read more
27 Apr 2026 | Molecular Diagnostics
Image: Myalgic encephalomyelitis (ME) presents with heterogeneous, multisystem symptoms and post-exertional malaise, with overlap with conditions like fibromyalgia complicating diagnosis (photo courtesy of Shutterstock)

Epigenetic Signals and Blood Markers Aid Chronic Fatigue Syndrome Diagnosis

Myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome, presents with heterogeneous symptoms and a hallmark of post‑exertional malaise that complicate clinical assessment. Read more
27 Apr 2026 | BioResearch
Image: Biosensor for tuberculosis detection (photo courtesy of UPV)

Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour

Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. Read more
27 Apr 2026 | Microbiology
Photo courtesy of Adobe Stock

Gene Expression Model Guides Neoadjuvant Therapy Selection in Breast Cancer

Predicting which patients with early breast cancer will benefit from chemotherapy before surgery remains difficult. Read more
27 Apr 2026 | Molecular Diagnostics
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Collaboration Expands Access to Rapid Metagenomic Diagnostics for Complex Infections

Hospitals are seeing rising rates of complicated and healthcare-associated infections, especially in immunocompromised patients, intensifying the need for rapid, comprehensive pathogen detection. Read more
27 Apr 2026 | Industry
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Read more
25 Apr 2026 | Pathology
Image: Tumor cells (red) actively engage neighboring cells (green) to create a local environment that supports tumor growth, a new study from the lab of Dr. Joo-Hyeon Lee shows. The findings could eventually help doctors to better detect and treat cancer in its early stages (photo courtesy of Memorial Sloan Kettering Cancer Center)

Microenvironment Biomarkers Could Enable Early Lung Cancer Detection

Early detection of lung cancer remains difficult because the first cellular changes unfold within a shifting local niche. Read more
25 Apr 2026 | BioResearch
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Read more
25 Apr 2026 | Clinical Chem.
Image: Overview of the MorphoGenie framework (Murthy, R.S., Stassen, S.V., Siu, D.M.D. et al. Nat Commun 16, 11465 (2025). doi.org/10.1038/s41467-025-66267-w)

Interpretable AI Reveals Hidden Cellular Features from Microscopy Images

Microscopy images contain rich clues about cell health, but many disease-relevant morphological differences are too subtle to see and difficult to quantify consistently. Read more
24 Apr 2026 | Pathology

Channels

Clinical Chemistry

view channel
Label-Free Microfluidic Device Enriches Tumor Cells and Clusters from Pleural Ef...
Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection
Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designa...
Image: An elevated neutrophil-to-lymphocyte ratio (NLR), a rato easily obtained from a routine blood count, was associated with both short- and long-term Alzheimer’s risk (photo credit: 123RF)

Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

Alzheimer’s disease and related dementias develop over years, making it difficult to identify at-risk patients before symptoms appear. Clinicians therefore need widely available laboratory markers that... Read more

Molecular Diagnostics

view channel
Cancer-Related Mutations in Immune Cells Linked to Alzheimer’s
Composite Blood Biomarkers Enable Early Detection of Common Cancers
Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of...
Image: Curve Biosciences’ Whole-Body Intelligence platform uses AI and the company's Whole-Body Atlas to uncover organ-specific biology from blood (photo courtesy of Curve Biosciences)

AI Blood Test Enhances Monitoring of Liver Cirrhosis Progression

Monitoring chronic liver disease remains difficult because clinicians rely on tools that can be inconsistent and may miss early progression. Standard approaches often combine ultrasound imaging with blood-based... Read more

Hematology

view channel
Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
Image

Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching

CareDx (Brisbane, CA, USA) has introduced AlloSeq Nano, a nanopore‑based HLA (human leukocyte antigen) and ABO genotyping solution unveiled at the European Federation for Immunogenetics (EFI) Conference 2026.... Read more

Immunology

view channel
Study Finds Influenza Often Undiagnosed in Winter Deaths
Combined Screening Approach Identifies Early Leprosy Cases
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
Image: Graphical abstract - Human immune aging clock identifies RUNX1 as a decelerator of T cell senescence (photo courtesy of Zhang Weiqi)

Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target

Immune aging undermines host defense and contributes to multiple age-related diseases, yet its heterogeneity complicates measurement and intervention. Clinical laboratories increasingly seek objective... Read more

Microbiology

view channel
Label-Free Microscopy Methodd Enables Faster, Quantitative Detection of Malaria
Gut Microbiome Test Predicts Melanoma Recurrence After Surgery
Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infe...
Image: Graphical abstract (Qin, Y. et al., Cell Rep Med 7: 102761 (2026). DOI: 10.1016/j.xcrm.2026.102761)

Oral–Gut Microbiome Signatures Identify Early Gastric Cancer

Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read more

Pathology

view channel
Plug-and-Play AI Pathology System Classifies Multiple Cancers from Few Slides
AI-Based Assays Support Risk Stratification in Prostate and Breast Cancer
AI Pathology Model Predicts Immunotherapy Response in Lung Cancer
Image: The findings show that patients with tumors harboring active networks of cytotoxic T cells were more likely to benefit from treatment, whereas those with dense clusters of plasma cells were significantly less likely to respond (photo courtesy of Shutterstock)

Tumor Immune Structure Predicts Response to Immunotherapy in Melanoma

Many patients with advanced melanoma start on anti-PD-1 immunotherapy, but responses can wane or never develop. Clinicians often turn to anti-CTLA-4 after resistance emerges, yet predicting who will respond... Read more

Technology

view channel
Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
Noninvasive Sputum Test Detects Early Lung Cancer
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Image: Flow chart summarizing workflow pipeline (Thomas, V., Nyamundanda, G., Lärkeryd, A. et al. Sci Rep 16, 8843 (2026). https://doi.org/10.1038/s41598-026-39189-w)

AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer

Advanced bowel cancer remains difficult to treat, and many patients receive targeted therapies that do not help them but still cause harm. Clinicians need reliable ways to identify likely responders before... Read more

Industry

view channel
Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID
Roche Affiliate Expands MRD Portfolio with SAGA Acquisition
Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and...
Image: The acquisition adds the LEX VELO System to QuidelOrtho’s portfolio (photo courtesy of LEX Diagnostics)

QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition

QuidelOrtho Corporation has completed the acquisition of LEX Diagnostics for approximately USD 100 million in cash. The transaction adds the LEX VELO System to QuidelOrtho’s portfolio. The platform received U.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE